Australia to Ban Non-Prescription Vapes in Major Reform

May.02.2023
Australia to Ban Non-Prescription Vapes in Major Reform
Australia bans non-prescription e-cigarettes, sets quality standards, and invests $234 million in smoking reforms.

On May 1st, according to a report from The Guardian, Australian Health Minister Mark Butler announced that the government will ban the importation of non-prescription electronic cigarette products. The government will also establish minimum quality standards which will include restricting e-cigarette flavors, packaging colors, and other ingredients. Similar to pharmaceuticals, packaging will indicate reduced nicotine concentration and capacity. Additionally, single-use e-cigarettes will be explicitly prohibited.


Determined to eliminate the "public health threat".


A previous investigation was conducted by Australia's Therapeutic Goods Administration (TGA) on the regulation reform of e-cigarettes within the country. The majority of materials submitted by relevant health organizations supported increasing border control.


They believe that the focus of border control is on non-nicotine electronic cigarette products.


Electronic cigarette manufacturers have falsely labeled products containing nicotine as "nicotine-free" to circumvent import restrictions.


This makes it easy for children to buy electronic cigarettes and often unknowingly inhale nicotine, leading to addiction.


The Minister of Health, Mr. Butler, said in a television program that the tobacco industry is attempting to create a "new generation of nicotine addicts" through the production of e-cigarettes. He stated that he is determined to eliminate this public health threat.


The Australian government will collaborate with states and territories to put an end to the sale of electronic cigarettes in convenience stores and other retail shops. They will also establish stricter guidelines for the sale of e-cigarette products in pharmacies, in order to ensure the contents are safe for consumers.


The largest loophole in Australian history


Butler is expected to outline these reforms in a speech at the National Press Club. According to a leaked copy of the speech, Butler believes that e-cigarettes have become "the biggest loophole in Australian history" and has announced that the government will invest AUD 234 million (approximately RMB 1.07 billion) into reforms relating to tobacco and e-cigarettes.


The speech by Butler stated that electronic cigarettes are being marketed as a therapeutic product to governments and communities around the world to aid long-term smokers in quitting.


It was never intended to be sold as an entertainment product, especially not one suitable for our children. But that is what it has become: the biggest loophole in Australian history.


A sum of 63 million Australian dollars (approximately 289 million yuan) will be utilized for public health advocacy campaigns aimed at preventing smoking and the use of e-cigarettes while also promoting smoking cessation.


Additionally, 30 million Australian dollars (approximately 138 million Chinese yuan) will be invested in a support program to help Australians quit smoking, and there will be an increased effort to educate and train healthcare professionals on smoking cessation and nicotine addiction.


According to Terry Slevin, CEO of the Australian Public Health Association, the upcoming reforms by the Australian government describe electronic cigarettes as a "public health disaster". He stated that the reforms will make Australia a world leader in controlling tobacco and e-cigarettes.


Laura Hunter, joint CEO of the Australian Smoking and Health Council, says it is encouraging to see the government take decisive action against a harmful industry.


She stated that the government's plan is largely normalizing the culture of e-cigarettes.


Further reading:


Australia may implement a complete ban on imported electronic cigarettes.


An Australian state plans to broaden the scope of smoke-free public spaces and double fines for selling e-cigarettes to minors.


Australia to introduce plain packaging and flavor bans, and strengthen border control measures.


Reference list:


Australia is set to implement its most significant smoking reforms in a decade by banning the sale of non-prescription vapes.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine's Cabinet of Ministers adopted Resolution No. 1259 on October 15, 2026, increasing excise stamp production fees for tobacco products and e-cigarette liquids by approximately 30.5%, from UAH 0.1643 to UAH 0.2144 per stamp. Fees for alcoholic beverages rose by about 30.2%. Separately, Ukraine's parliament passed Bill No. 15532 on October 13, proposing to postpone the full implementation of electronic excise stamps and traceability for alcohol, tobacco and e-cigarette liquids from November 1, 2026, to July 1, 2027. Parliament cited additional testing, configuration and integration requirements. The bill was sent to the president for signature on October 19.
Regulations
Oct.21
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10